By LINDA A. JOHNSON, AP Medical Writer CVS has halted sales of popular heartburn treatment Zantac and its generic store brand after warnings by U.S. health regulators. It's the latest precautionary move by retailers and manufacturers after the U.S. Food and Drug Administration recently warned consumers about a potentially dangerous contaminant in prescription and over-the-counter versions of Zantac.